Cargando…
Evaluation of Pharmacokinetics, and Bioavailability of Higher Doses of Tocotrienols in Healthy Fed Humans
BACKGROUND: Tocotrienols has been known to lower serum lipid parameters below 500 mg/d, while increase lipid parameters at higher dose of 750 mg/d. δ-Tocotrienol has a novel inflammatory property of concentration-dependent inhibition and activation. Therefore, inhibition (anti-inflammatory) property...
Autores principales: | Qureshi, Asaf A, Khan, Dilshad A, Silswal, Neerupma, Saleem, Shahid, Qureshi, Nilofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968874/ https://www.ncbi.nlm.nih.gov/pubmed/27493840 http://dx.doi.org/10.4172/2155-9880.1000434 |
Ejemplares similares
-
Proteasome inhibitors modulate anticancer and anti-proliferative properties via NF-kB signaling, and ubiquitin-proteasome pathways in cancer cell lines of different organs
por: Qureshi, Asaf A., et al.
Publicado: (2018) -
δ-Tocotrienol feeding modulates gene expression of EIF2, mTOR, protein ubiquitination through multiple-signaling pathways in chronic hepatitis C patients
por: Qureshi, Asaf A., et al.
Publicado: (2018) -
Tocotrienols inhibit lipopolysaccharide-induced pro-inflammatory cytokines in macrophages of female mice
por: Qureshi, Asaf A, et al.
Publicado: (2010) -
Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II
por: Qureshi, Asaf A
Publicado: (2022) -
Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries
por: Qureshi, Asaf A, et al.
Publicado: (2011)